Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2002 May;86(5):365-9.
doi: 10.1136/adc.86.5.365.

The effect of brief neonatal exposure to cows' milk on atopic symptoms up to age 5

Affiliations
Clinical Trial

The effect of brief neonatal exposure to cows' milk on atopic symptoms up to age 5

M H de Jong et al. Arch Dis Child. 2002 May.

Abstract

Aims: To determine the effect of brief early exposure to cows' milk on the expression of atopy during the first five years of life.

Methods: Follow up analysis of a double blind, placebo controlled, randomised feeding intervention trial (BOKAAL study). Subjects were 1108 children from 1533 initially randomised breast fed neonates in the Netherlands. Atopic disease and prevalence of allergic symptoms at age 1, 2, and 5, and specific IgE at age 1 and 5 were determined.

Results: Atopic disease in the first year was found in 10.0% (cows' milk) versus 9.3% (placebo) of the children, with a relative risk (RR) of 1.07. No differences were found in the second year either. At age 5, atopic disease was found in 26.3% (cows' milk) versus 25.0% (placebo), RR 1.05. There was no difference in the prevalence of allergic symptoms. Specific IgE to cows' milk (RAST positive 2+ or more) was 5.8% (cows' milk) versus 4.1% (placebo) at age 1 (RR 1.43), and 5.3% versus 3.0% at age 5 (RR 1.77). There was no difference in sensitisation to other common allergens between the two groups.

Conclusion: Early, brief exposure to cows' milk in breast fed children is not associated with atopic disease or allergic symptoms up to age 5.

PubMed Disclaimer

References

    1. Br Med J (Clin Res Ed). 1981 Sep 12;283(6293):693-6 - PubMed
    1. BMJ. 1990 May 19;300(6735):1306-10 - PubMed
    1. Arch Dis Child. 1992 Aug;67(8):1008-10 - PubMed
    1. Pediatr Allergy Immunol. 1994;5(5 Suppl):1-36 - PubMed
    1. Eur Respir J. 1995 Mar;8(3):483-91 - PubMed

Publication types

Substances